Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries. - Linde L; Georgiadis S; Ørnbjerg LM; Rasmussen SH; Michelsen B; Askling J; Di Giuseppe D; Wallman JK; Závada J; Pavelka K; Bernardes M; Matos CO; et al. (Arthritis care & research, 2024)